CClinicalTrials.gg
RecruitingNCT06981208Updated Jun 10, 2026

ChatGPT & Surgeon Synergy: Redefining Breast Reconstruction Consultations for Enhanced Patient Engagement and Satisfaction

An interventional study of ChatGPT-generated patient education and Usual patient education in Breast Cancer and Cancer of the Breast, sponsored by Washington University School of Medicine. Recruiting at 1 site in United States. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-06-10.

Sponsored by Washington University School of Medicine · Not applicable, Interventional, and Health services research

From the registry’s dates

  • Started Jun 2025; still recruiting 1 year 4 months later.
Phase
Not applicable
Study type
Interventional
Enrollment
410
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

In this study, patients who are scheduled for breast reconstruction consultation will be randomized into the intervention group (ChatGPT-generated patient education regarding possible reconstruction options) or the control group (usual patient education). All patients will complete a survey following their in-person consultation to assess their experience and overall satisfaction with the consultation process. Additionally, participating surgeons will complete a separate survey to evaluate their consultation experience, satisfaction, and to assess the accuracy and clinical utility of the ChatGPT-generated patient education materials. The surveys are designed to gather information on patient characteristics, organizational health literacy according to Brega et al. Other survey questions have been designed to meet the outcomes of this study and have not been based on previously published surveys.

02

Conditions studied

  • Breast Cancer
  • Cancer of the Breast

Browse trials for

Keywords

  • Patient education
  • ChatGPT
  • Breast reconstruction
03

In context

Breast Neoplasms

12,544 studies on the registry are indexed under Breast Neoplasms; 2,892 are open to participants now.

This study's planned enrollment of 410 is above the median of 72 across 9,303 interventional studies indexed under Breast Neoplasms.

Browse Breast Neoplasms studies →

Lead sponsor

Washington University School of Medicine is the lead sponsor of 1,765 studies on the registry; 271 are open to participants now.

Of its 324 completed or terminated interventional studies of FDA-regulated products, 212 (65%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Eligibility criteria

Patient Eligibility Criteria:

  • Scheduled for initial preoperative breast reconstruction consultation following therapeutic or prophylactic mastectomy with a surgeon at Washington University School of Medicine.
  • At least 18 years of age.
  • Can speak and understand English.

Surgeon Eligibility Criteria:

  • Routinely performs breast reconstruction surgery at Washington University School of Medicine.
  • At least 18 years of age.
  • Can speak and understand English.
  • Surgeon must not be a resident or fellow at time of enrollment.
05

Study design

Phase
Not applicable
Primary purpose
Health services research
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Care provider)
Enrollment
410 participants (estimated)

Study arms

  • Experimental
    ChatGPT-generated patient education

    * Pre-consultation ChatGPT patient education: The patients randomized into the ChatGPT education group will receive a ChatGPT patient education on paper prior to their consultation. The ChatGPT will write a patient-tailored education regarding possible reconstruction options. The patient will review this independently, without additional input or guidance from a research team member * Patient post-consultation survey: All patients will receive a survey after the planned in-person consultation with the plastic surgeon.

    Other: ChatGPT-generated patient education

  • Active comparator
    Usual education

    \- Patients will not receive any additional information prior to their consultation.

    Other: Usual patient education

  • No intervention
    Surgeons

    * In order for the surgeon to be blinded to the study arm, all participants will have ChatGPT education created. Participating surgeons will review each patient education sheet prior to the consult and score the accuracy of the provided education sheet. The surgeon will proceed with the consultation as planned. The surgeon is blinded to the patient's study arm as they will be reviewing ChatGPT education for all patients. If any inaccuracies are identified in the patient education sheet, the surgeon will address this with the study team and have the errors fixed prior to providing to the patient. * The surgeon will receive a survey after each in-person consultation, covering patient experience, surgeon experience, and education material accuracy.

Interventions

  • OtherChatGPT-generated patient education

    This is created by entering the patient's age, medical history, social history, and case-specific details into Washington University ChatGPT Beta (HIPAA and FERPA compliant) by a study team member.

  • OtherUsual patient education

    Usual patient education will include description of breast reconstruction options, with further elaboration on which option are more suitable to the patient. This include also review of risk of complications and expected recovery after surgery.

06

What researchers measure

Primary outcomes

  1. Patient perceived understanding of breast reconstruction

    The patient will choose an answer ranging from 0-100 (strongly disagree to strongly agree). The higher the score, the more perceived understanding the patient had.

    Time frame: Pre-surgical consultation (day 1)

Secondary outcomes

  1. Patient satisfaction with education regarding breast reconstruction

    The patient will choose an answer ranging from 0-100 (strongly disagree to strongly agree). The higher the score, the more satisfied the patient was.

    Time frame: Pre-surgical consultation (day 1)

  2. Surgeon satisfaction with the consultation process

    Survey includes two question regarding surgeon's satisfaction with the consultation process. The surgeon will choose an answer ranging from 0-100 (strongly disagree to strongly agree). The higher the score, the more satisfied the surgeon was with the consultation process.

    Time frame: Pre-surgical consultation (day 1)

  3. Surgeon perception of patient preparedness

    Survey includes one question regarding patient preparedness. The surgeon will choose an answer ranging from 0-100 (strongly disagree to strongly agree). The higher the score, the more prepared the surgeon felt the patient was.

    Time frame: Pre-surgical consultation (day 1)

  4. Surgeon views on the efficiency of the consultation

    Survey includes one question regarding efficiency of the consultation. The surgeon will choose an answer ranging from 0-100 (strongly disagree to strongly agree). The higher the score, the more efficient the surgeon felt the consult was.

    Time frame: Pre-surgical consultation (day 1)

  5. Surgeon overall experience with the consultation

    Survey includes one question regarding the pre-surgical consultation overall experience. The surgeon will choose an answer ranging from 0-100 (strongly disagree to strongly agree). The higher the score, the better the overall experience was.

    Time frame: Pre-surgical consultation (day 1)

07

Study locations

1 of 1 sites recruiting
  • Washington University School of Medicine
    St Louis, Missouri 63110, United States
    • Saif M Badran, M.D., Ph.D., FRCS · Contact · badran@wustl.edu · 314-273-1434
    • Saif M Badran, M.D., Ph.D., FRCS · Principal investigator
    • Justin M Sacks, M.D., MBA, FACS · Sub investigator
    Recruiting
08

References and documents

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jun 10, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06981208
Lead sponsor
Washington University School of Medicine
Responsible party
Sponsor
First posted
May 20, 2025
Start date
Jun 3, 2025
Primary completion
Jun 30, 2028 (estimated)
Completion
Jun 30, 2028 (estimated)
Last update
Jun 10, 2026

Study contacts

Saif M Badran, M.D., Ph.D., FRCS
Contact
badran@wustl.edu
314-273-1434
Saif M Badran, M.D., Ph.D., FRCS
principal investigator · Washington University School of Medicine

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion